| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2513-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07 |
| filingDate |
2020-10-26^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f7710f08822d260e00c1647df2744fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c77ce7a37276747e631722f3081bafc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d714d3eee4fa5a8fa5aabf6b197331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68a9558afe9f0c1affc61b1199ab5f0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c2f2a5b04849b0a3398617ae4af9164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ab83a27be18b912078971040488654d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2607ad89e11b3a5e72c82804da53299
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dba54a6d01edc7cf561dd3b247f9c62 |
| publicationDate |
2021-04-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021081491-A2 |
| titleOfInvention |
Patient-matched organoid systems for studying cancer |
| abstract |
In certain example embodiments, the invention provides a method of generating an ex vivo cell-based system comprising dissociating an original tissue sample obtained from a subject into a single cell population; determining an in vivo phenotype of the tissue sample by conducting single-cell RNA analysis on a first portion of the single cells; establishing an ex vivo cell-based system from a second portion of the single cells; and culturing the ex vivo cell-based system in a medium or conditions selected to maintain the in vivo phenotype. In some embodiments, the original tissue sample is a tumor tissue sample, such as a pancreatic ductal adenocarcinoma (PDAC) tumor sample. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114480289-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114736852-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023069652-A1 |
| priorityDate |
2019-10-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |